Our findings provide the basis to further dissect the role of PLAC1 in the ERα-signaling pathway in breast cancer and suggest PLAC1 as a novel target gene of NCOA3 in ERα-positive MCF-7 breast cancer cells supporting the role of both factors in breast cancer biology. Here, ESR1 is linked to breast carcinoma.